Menora Mivtachim Holdings’s Novo Nordisk NVO Stock Holding History

Menora Mivtachim Holdings’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.4M	Hold	926,168	–	–	0.17%	94
2026 Q1	$34M	Buy	926,168 +650,000	+235%	+$30.8M	0.16%	84
2025 Q4	$14.1M	Buy	276,168 +6,000	+2%	+$307K	0.07%	80
2025 Q3	$15M	Hold	270,168	–	–	0.08%	80
2025 Q2	$18.6M	Hold	270,168	–	–	0.11%	74
2025 Q1	$18.8M	Sell	270,168 -572,800	-68%	-$47.3M	0.12%	72
2024 Q4	$72.5M	Buy	+842,968	New	+$91.2M	0.45%	57
2017 Q1	–	Sell	-7,660	Closed	-$137K	–	100
2016 Q4	$137K	Buy	+7,660	New	+$139K	0.01%	90

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Menora Mivtachim Holdings's NVO Position: Q2 2026 in Review

Menora Mivtachim Holdings held its Novo Nordisk (NVO) position steady in Q2 2026 at 926,168 shares worth $44.4M. The position accounts for 0.17% of the portfolio, ranked #94.

Menora Mivtachim Holdings first reported a position in NVO in Q4 2016 and has held it in 8 quarters since. The position peaked at $72.5M in Q4 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Menora Mivtachim Holdings held 926,168 shares of Novo Nordisk worth $44.4M as of Q2 2026.
Menora Mivtachim Holdings left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.17% of Menora Mivtachim Holdings's portfolio in Q2 2026, its #94 holding.
Menora Mivtachim Holdings first reported a position in Novo Nordisk in Q4 2016 and has held it in 8 quarters since.
Menora Mivtachim Holdings's Novo Nordisk position peaked at $72.5M in Q4 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Menora Mivtachim Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.